Progressive dopamine neuron loss in Parkinson's disease: The multiple hit hypothesis

被引:122
作者
Carvey, Paul M.
Punati, Ashok
Newman, Mary B.
机构
[1] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA
[2] Rush Univ, Dept Neurosci Program, Chicago, IL 60612 USA
关键词
Parkinson's disease; dopamine neurons; progression multiple hit hypothesis;
D O I
10.3727/000000006783981990
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Animal models have been an essential tool for researchers and clinicians in their efforts to study and treat Parkinson's disease (PD). Thus, the various ways 6-hydroxydopamine is employed, the use of MPTP in rodents and nonhuman primates, the prenatal exposure to bacterial endotoxin, the postnatal exposure to environmental toxins such as paraquat and rotenone, the assessment of dopamine (DA) neurons in genetic knockout mouse, and even the behavioral analysis of fruit flies and worms have added significantly to our knowledge base of PD-or have they? Are these animal models manifesting a true model of PD? Have the 7786 published studies (to date) on PD with animal models led to a clearer understanding of its etiology, treatment, or progression? In this review we critically assess this question. We begin with a succinct history of the major contributions, which have led to the current animal models of PD. We then evaluate the primary issue of the progressive loss of DA neurons, which, except for a few studies, has not been addressed in animal models of PD, even though this is the major pathological characteristic of the disease. Lastly, we discuss the possibility that more than one risk factor for PD may be necessary to develop an animal model that shows synergy-the progressive loss of DA neurons. Thus, the multiple hit hypothesis of PD-that is, the effect of more then one risk factor-may be the start of new era in animal models of PD that is one step closer to mimicking the pathology of PD in humans.
引用
收藏
页码:239 / 250
页数:12
相关论文
共 96 条
  • [1] CHRONIC ADMINISTRATION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE TO MONKEYS - BEHAVIORAL, MORPHOLOGICAL AND BIOCHEMICAL CORRELATES
    ALBANESE, A
    GRANATA, R
    GREGORI, B
    PICCARDI, MP
    COLOSIMO, C
    TONALI, P
    [J]. NEUROSCIENCE, 1993, 55 (03) : 823 - 832
  • [2] [Anonymous], [No title captured]
  • [3] Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT:: preliminary findings in one patient with autosomal recessive parkinsonism (Park2)
    Antonini, A
    Moresco, RM
    Gobbo, C
    De Notaris, R
    Panzacchi, A
    Barone, P
    Bonifati, V
    Pezzoli, G
    Fazio, F
    [J]. NEUROLOGICAL SCIENCES, 2002, 23 (Suppl 2) : S51 - S52
  • [4] COMPARATIVE BEHAVIORAL, BIOCHEMICAL AND PIGMENTARY EFFECTS OF MPTP, MPP+ AND PARAQUAT IN RANA-PIPIENS
    BARBEAU, A
    DALLAIRE, L
    BUU, NT
    POIRIER, J
    RUCINSKA, E
    [J]. LIFE SCIENCES, 1985, 37 (16) : 1529 - 1538
  • [5] A fetal risk factor for Parkinson's disease
    Barlow, BK
    Richfield, EK
    Cory-Slechta, DA
    Thiruchelvam, M
    [J]. DEVELOPMENTAL NEUROSCIENCE, 2004, 26 (01) : 11 - 23
  • [6] Bertrand E, 1997, FOLIA NEUROPATHOL, V35, P80
  • [7] Chronic systemic pesticide exposure reproduces features of Parkinson's disease
    Betarbet, R
    Sherer, TB
    MacKenzie, G
    Garcia-Osuna, M
    Panov, AV
    Greenamyre, JT
    [J]. NATURE NEUROSCIENCE, 2000, 3 (12) : 1301 - 1306
  • [8] A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey
    Bezard, E
    Imbert, C
    Deloire, X
    Bioulac, B
    Gross, CE
    [J]. BRAIN RESEARCH, 1997, 766 (1-2) : 107 - 112
  • [9] Kinetics of nigral degeneration in a chronic model of MPTP-treated mice
    Bezard, E
    Dovero, S
    Bioulac, B
    Gross, CE
    [J]. NEUROSCIENCE LETTERS, 1997, 234 (01) : 47 - 50
  • [10] BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787